Nanograb

About

Nanograb is a computational drug discovery company that uses AI to create novel targeted non-viral gene therapy vectors. Our platform designs unique combinations of small peptide binders attached to nanoparticles to safely deliver genetic medicines to specific cells and tissues in the body at scale.

Founders

• 
  Debesh Mandal· Founder

  Co-founder and CEO of Nanograb. PhD in Computational Biophysics from Imperial College London. Experienced in molecular simulations and building software for scientists. First software hire at Fabricnano

  LinkedIn ↗
• 
  Christopher Lau· Founder

  Co-founder of Nanograb. M.Eng Biomaterials and Tissue Engineering at Imperial College London. Biomedical engineering experience developing biosensors using aptamers, and a drug delivery device for hypertension management.

  LinkedIn ↗Twitter ↗
• 
  Shanil Panara· Founder

  Cofounder and in silico lead at Nanograb; Imperial College PhD (dropout); Fascinated by all things compute and physics... all in the name of figuring out real life things! Otherwise, I love singing and music in general. Fun fact: I was in an a cappella group for 5 years :)

  LinkedIn ↗Twitter ↗

Product launches · 1 launch

• 🧪 Nanograb - Multivalent nanoparticles for next-generation targeted drugs ↗▲ 159Jul 29, 2023

  We use AI to generate the best combination of binders to treat different diseases

Change history · none recorded